Monash Biomedical Imaging

MBI also provides access to certified radiochemistry facilities for the handling of radionuclides, with in-house expertise for the development of radiopharmaceuticals for preclinical and clinical applications. This capability will be further expanded through the Monash University Cyclotron Facility, due to become operational by the end of 2028. The new facility will house an 18–24 MeV medical cyclotron and provide local radioisotope production and GMP-compliant radiopharmaceutical manufacturing and radiochemistry services, supporting translation from research through clinical trials and into clinical use.

MBI’s sites in Clayton and Prahran are uniquely co-located with the Australian Synchrotron, Monash University and the Alfred Hospital, enabling a broad range of ancillary research, contract research support and translational capabilities.